Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA
Authors:
- Beatrice GachieBGBeatrice Gachie
- Jean ChepngetichJCJean Chepngetich
- Brenda MuriithiBMBrenda Muriithi
- Kelvin Thiong’oKTKelvin Thiong’o
- Jeremiah GathirwaJGJeremiah Gathirwa
- Francis KimaniFKFrancis Kimani
- Peter MwitariPMPeter Mwitari
- Gabriel MagomaGMGabriel Magoma
- Daniel KiboiDKDaniel Kiboi
Open Access
- 8 September 2023
- journal article
- research article
- Published by F1000 Research Ltd in Open Research Africa
- Vol. 5, 27
Abstract
Background: Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. The recent report on the emergence of artemisinin-resistant parasites portends an imminent failure of the partner drug in clearing the high residual parasite densities. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (nfs1), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance. Methods: Using the rodent malaria parasites Plasmodium berghei ANKA in mice, we assessed whether the nfs1 gene is associated with LM, PQ, and AQ resistance. We first verified the stability of the LM, PQ, and AQ-resistant parasites in the standard 4-Day Suppressive Test. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) in the nfs1 gene. Using qPCR, we then measured the expression of the nfs1 gene in resistant parasites relative to the drug-sensitive parent parasites. Results: Our analyses of nfs1 reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the nfs1 gene reveals differential expression in both LM and PQ-resistant parasites. Conversely, nfs1 expression remained unchanged in the AQ-resistant parasites. Conclusion: Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and differential expression of the nfs1 gene in Plasmodium berghei. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both P. berghei and P. falciparum.Keywords
Funding Information
- The African Union Commission under the Pan African University Institute for Basic Sciences, Technology, and Innovation (PhD fellowship No: MB400-0003/2019 | award to BG)
- AFRICA-ai-JAPAN Project: JICA Innovation Research Fund (JKU/ADM/10B)
This publication has 31 references indexed in Scilit:
- Parasites FeS Up: Iron-Sulfur Cluster Biogenesis in Eukaryotic PathogensPLOS Pathogens, 2013
- Role ofpfmdr1Amplification and Expression in Induction of Resistance to Artemisinin Derivatives inPlasmodium falciparumAntimicrobial Agents and Chemotherapy, 2010
- Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquineProceedings of the National Academy of Sciences, 2009
- Function and biogenesis of iron–sulphur proteinsNature, 2009
- Plasmodium berghei ANKA: Selection of resistance to piperaquine and lumefantrine in a mouse modelExperimental Parasitology, 2009
- Chloroquine resistance before and after its withdrawal in KenyaMalaria Journal, 2009
- Decreasingpfmdr1Copy Number inPlasmodium falciparumMalaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and ArtemisininThe Journal of Infectious Diseases, 2006
- High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium bergheiNature Protocols, 2006
- Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum MalariaClinical Infectious Diseases, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001